Neoadjuvant chemotherapy for Ewing's tumour of bone: recent experience at the Rizzoli Orthopaedic Institute.

@article{Bacci2002NeoadjuvantCF,
  title={Neoadjuvant chemotherapy for Ewing's tumour of bone: recent experience at the Rizzoli Orthopaedic Institute.},
  author={Gaetano Bacci and M. Cristina Mercuri and Alessandra Longhi and Franco Bertoni and Enza Barbieri and Davide Donati and Stefano Giacomini and Patrizia Bacchini and Elettra Pignotti and Cristiana Forni and Stefano Ferrari},
  journal={European journal of cancer},
  year={2002},
  volume={38 17},
  pages={2243-51}
}
The results achieved in 157 patients with non-metastatic Ewing's sarcoma of the bone treated at a single institution between 1991 and 1997 according to a new protocol (REN-3) are reported. Induction chemotherapy consisted of two cycles of 'VAC': vincristine (V), doxorubicin (A), cyclophosphamide (C) alternated with one cycle of 'VIAc': V, ifosfamide (I… CONTINUE READING